Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Centre Number
Item
Centre Number
text
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Have liver chemistry results reached or exceeded protocol-defined investigational product stopping criteria?
Item
Have liver chemistry results reached or exceeded protocol-defined investigational product stopping criteria?
boolean
C0232741 (UMLS CUI [1])
C0008000 (UMLS CUI [2])
C0304229 (UMLS CUI [3,1])
C2746065 (UMLS CUI [3,2])
C0243161 (UMLS CUI [3,3])
Date of liver biopsy
Item
Date of liver biopsy
date
C0193388 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Approximate size of liver biopsy
Item
Approximate size of liver biopsy
float
C1299482 (UMLS CUI [1,1])
C0193388 (UMLS CUI [1,2])
Item
A. Final Diagnosis
text
C1546485 (UMLS CUI [1])
Code List
A. Final Diagnosis
CL Item
Acute hepatitis (A1)
CL Item
Chronic hepatitis (A2)
CL Item
Cholestatic hepatitis (A3)
CL Item
Drug-induced cholestasis (A4)
CL Item
Acute viral hepatitis (A5)
CL Item
Chronic viral hepatitis (A6)
CL Item
Drug-induced hepatitis (A7)
CL Item
Autoimmune hepatitis (A8)
CL Item
Bridging necrosis (A9)
CL Item
Submassive hepatic necrosis (A10)
CL Item
Massive hepatic necrosis (A11)
CL Item
Steatosis - microvesicular (A12)
CL Item
Steatosis - macrovesicular (A13)
CL Item
Steatosis - mixed (A14)
CL Item
Non-alcoholic steatohepatitis (A15)
CL Item
Alcoholic hepatitis (A16)
CL Item
Hepatic granulomas (A17)
CL Item
Sarcoidosis (A18)
CL Item
Primary biliary cirrhosis (A21)
CL Item
Primary sclerosing cholangitis (A22)
CL Item
Autoimmune overlap syndrome (A23)
CL Item
Hemochromatosis (A24)
CL Item
Alpha-1-antitrypsin deficiency (A25)
CL Item
Wilson’s disease (A26)
CL Item
Veno-occlusive disease (A27)
CL Item
Budd-Chiari syndrome (A28)
CL Item
Other, specify (A99)
Specify other Final Diagnosis
Item
Specify other Final Diagnosis
text
C1546485 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [2])
Item
B. Liver Architecture
text
C0023884 (UMLS CUI [1,1])
C0935919 (UMLS CUI [1,2])
Code List
B. Liver Architecture
CL Item
Bridging fibrosis (B2)
CL Item
Diffuse fibrosis (B3)
CL Item
Nodular regenerative hyperplasia (B4)
CL Item
Congenital hepatic fibrosis (B5)
CL Item
Centrilobular congestion (B7)
CL Item
Endophlebitis (B8)
CL Item
Veno-occlusive disease (B9)
CL Item
Canalicular cholestasis (B10)
CL Item
Focal (or spotty or mild) hepatocellular necrosis (B12)
CL Item
Interface hepatitis (periportal hepatitis or piecemeal necrosis) (B13)
CL Item
Ischaemic necrosis (B14)
CL Item
Centrolobular (Zone 3) necrosis (B15)
CL Item
Focal coagulative necrosis (B16)
CL Item
Centrolobular (Zone 3) coagulative necrosis (B17)
CL Item
Bridging hepatocellular necrosis (B18)
CL Item
Massive or panlobular hepatocellular necrosis (B19)
CL Item
Other, specify (B99)
Specify other Liver Architecture
Item
Specify other Liver Architecture
text
C0023884 (UMLS CUI [1,1])
C0935919 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [2])
Item
C. Description of Liver or Hepatocytes
text
C0227525 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
Code List
C. Description of Liver or Hepatocytes
CL Item
Pseudoxanthomatous (C3)
CL Item
Multinucleated giant hepatocytes (C4)
CL Item
Other, specify (C99)
Specify other Liver or Hepatocytes
Item
Specify other Liver or Hepatocytes
text
C0227525 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Item
D. Liver Cell or Hepatocyte Inclusions or Vacuoles
text
C0227525 (UMLS CUI [1])
C0042219 (UMLS CUI [2])
C1512693 (UMLS CUI [3])
Code List
D. Liver Cell or Hepatocyte Inclusions or Vacuoles
CL Item
No inclusions (D0)
CL Item
Macrovesicular steatosis (D1)
CL Item
Microvesicular steatosis (D2)
CL Item
Bile accumulation (D3)
CL Item
Diastase-resistant, PAS-positive cytoplasmic inclusions (D4)
CL Item
Alpha-1-antitrypsin inclusions (D5)
CL Item
Megamitochondria (D6)
CL Item
Mallory bodies (D7)
CL Item
"Ground Glass" inclusions (D8)
CL Item
Lipofuscin pigment (D9)
CL Item
Hemosiderin granules (D10)
CL Item
Orcein-positive cytoplasmin granules (D11)
CL Item
Protoporphyrin crystals (birefringent under polarised light) (D12)
CL Item
Uroporphyrin crystals (red fluorescence under ultraviolet light) (D13)
CL Item
Other, specify (D99)
Specify other Liver Cell or Hepatocyte Inclusions or Vacuoles
Item
Specify other Liver Cell or Hepatocyte Inclusions or Vacuoles
text
C0227525 (UMLS CUI [1])
C0042219 (UMLS CUI [2])
C1512693 (UMLS CUI [3])
C0205394 (UMLS CUI [4])
C2348235 (UMLS CUI [5])
Item
E. Hepatocyte or Liver Cell Nuclear Abnormalities
text
C0227525 (UMLS CUI [1])
C1849376 (UMLS CUI [2,1])
C0193388 (UMLS CUI [2,2])
Code List
E. Hepatocyte or Liver Cell Nuclear Abnormalities
CL Item
Hepatocellular mitoses (E1)
CL Item
Binucleated or multinucleated hepatocytes (E2)
CL Item
CMV inclusion bodies (E3)
CL Item
HSV inclusions (E4)
CL Item
Varicella inclusions (E5)
CL Item
Other, specify (E99)
Specify other Hepatocyte or Liver Cell Nuclear Abnormalities
Item
Specify other Hepatocyte or Liver Cell Nuclear Abnormalities
text
C0227525 (UMLS CUI [1])
C1849376 (UMLS CUI [2,1])
C0193388 (UMLS CUI [2,2])
C0205394 (UMLS CUI [3])
C2348235 (UMLS CUI [4])
Item
F. Liver or Lobular Infiltrates
text
C0205417 (UMLS CUI [1])
C1400896 (UMLS CUI [2])
Code List
F. Liver or Lobular Infiltrates
CL Item
Plasma cells (F3)
CL Item
Macrophages and proliferating Kupffer cells (F5)
CL Item
Other, specify (F99)
Specify other Liver or Lobular Infiltrates
Item
Specify other Liver or Lobular Infiltrates
text
C0205417 (UMLS CUI [1])
C1400896 (UMLS CUI [2])
C0205394 (UMLS CUI [3])
C2348235 (UMLS CUI [4])
Item
G. Portal Tract Inflammation
text
C3854488 (UMLS CUI [1])
Code List
G. Portal Tract Inflammation
CL Item
Lymphoid aggregates and/or follicles (G2)
CL Item
Plasma cells (G3)
CL Item
Histocytes and macrophages (G5)
CL Item
Other, specify (G99)
Specify other Portal Tract Inflammation
Item
Specify other Portal Tract Inflammation
text
C3854488 (UMLS CUI [1])
C0205394 (UMLS CUI [2])
C2348235 (UMLS CUI [3])
Item
H. Bile Ducts
text
C0005400 (UMLS CUI [1])
CL Item
Proliferation of bile ducts (bile ductular reaction) (H1)
CL Item
Dilation, degeneration or disruption of portal bile ducts (H2)
CL Item
Paucity of bile ducts (H3)
CL Item
Periductal fibrosis (H4)
CL Item
Other, specify (H99)
Specify other Bile Ducts
Item
Specify other Bile Ducts
text
C0005400 (UMLS CUI [1])
C0205394 (UMLS CUI [2])
C2348235 (UMLS CUI [3])
Item
I. Portal Veins
text
C0032718 (UMLS CUI [1])
Code List
I. Portal Veins
CL Item
Pyelophlebitis (I1)
CL Item
Thrombosis, sclerosis or occlusion of portal vein (I2)
CL Item
Neoplastic invasion of portal vein (I3)
CL Item
Granulomatous compression of portal vein (I4)
CL Item
Other, specif (I99)
Specify other Portal Veins
Item
Specify other Portal Veins
text
C0032718 (UMLS CUI [1])
C0205394 (UMLS CUI [2])
C2348235 (UMLS CUI [3])
Item
J. Liver Infections
text
C1112211 (UMLS CUI [1])
Code List
J. Liver Infections
CL Item
Leishmaniasis donovani (J1)
CL Item
Plasmodium falciparum (J2)
CL Item
Toxoplasmosis (J3)
CL Item
Cryptococcus neoformans (J4)
CL Item
Histoplasma capsulatum (J5)
CL Item
Mycobacterium tuberculosis (J6)
CL Item
Other mycobacterial species (J7)
CL Item
Other, specify (J99)
Specify other Liver Infection
Item
Specify other Liver Infection
text
C1112211 (UMLS CUI [1])
C0205394 (UMLS CUI [2])
C2348235 (UMLS CUI [3])
Item
K. Parasites or Ova
text
C0030498 (UMLS CUI [1])
C0555117 (UMLS CUI [2])
Code List
K. Parasites or Ova
CL Item
Schistosome and/or ova (K1)
CL Item
Ascaris and/or ova (K2)
CL Item
Toxocara and/or ova (K3)
CL Item
Echinococcus cysts (K4)
CL Item
Hepatic capillariasis worms and/or ova (K5)
CL Item
Other, specify (K99)
Specify other Parasites or Ova
Item
Specify other Parasites or Ova
text
C0030498 (UMLS CUI [1])
C0555117 (UMLS CUI [2])
C0205394 (UMLS CUI [3])
C2348235 (UMLS CUI [4])
Item
L. Histologic Staining or Additional Studies Obtained
text
C0487602 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
Code List
L. Histologic Staining or Additional Studies Obtained
CL Item
Haematoxylin and eosin (or H & E) (L1)
CL Item
Toluidine blue or Giemsa (L3)
CL Item
Prussian blue (L4)
CL Item
Periodic Acidic Schiff (PAS), with or without diastase (L5)
CL Item
Hall’s stain (L8)
CL Item
Gridley’s stain (L9)
CL Item
Rhodanine (copper) (L10)
CL Item
Rubeanic acid (copper) (L11)
CL Item
Orcein, aldehyde fuchsin or Victoria blue (L12)
CL Item
Electron microscopy (L13)
CL Item
Hepatitis A immunostains positive (L14)
CL Item
Hepatitis B core antigen or hepatitis B surface antibody immunostains positive (L15)
CL Item
Hepatitis D immunostains (L16)
CL Item
Other immunostains (L17)
CL Item
Other, specify (L99)
Specify other Histologic Staining or Additional Studies Obtained
Item
Specify other Histologic Staining or Additional Studies Obtained
text
C0487602 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
C0205394 (UMLS CUI [2])
C2348235 (UMLS CUI [3])
Item
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
text
C0023884 (UMLS CUI [1])
C0022885 (UMLS CUI [2])
C2746065 (UMLS CUI [3,1])
C0243161 (UMLS CUI [3,2])
Code List
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
CL Item
ALT (alanine aminotransferase) (1)
CL Item
AST (aspartate aminotransferase) (2)
CL Item
Total bilirubin (3)
CL Item
Alkaline phosphatase (4)
CL Item
5’ nucleotidase (5)
CL Item
Gammaglutamyltranspeptidase (6)
If the liver event occurred during treatment period record start date of investigational product for that treatment period.
Item
If the liver event occurred during treatment period record start date of investigational product for that treatment period.
date
C0023884 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2])
C0347984 (UMLS CUI [3])
C0304229 (UMLS CUI [4,1])
C0808070 (UMLS CUI [4,2])
If the liver event occurred during treatment period record stop date of investigational product for that treatment period.
Item
If the liver event occurred during treatment period record stop date of investigational product for that treatment period.
date
C0023884 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2])
C0347984 (UMLS CUI [3])
C0304229 (UMLS CUI [4,1])
C0806020 (UMLS CUI [4,2])
If the liver event occurred after treatment period record start date of investigational product for the most recent period prior to the liver event.
Item
If the liver event occurred after treatment period record start date of investigational product for the most recent period prior to the liver event.
date
C0023884 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0304229 (UMLS CUI [3])
C0808070 (UMLS CUI [4])
If the liver event occurred after treatment period record stop date of investigational product for the most recent period prior to the liver event.
Item
If the liver event occurred after treatment period record stop date of investigational product for the most recent period prior to the liver event.
date
C0023884 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0304229 (UMLS CUI [3])
C0806020 (UMLS CUI [4])
Is the subject age 55 or older?
Item
Is the subject age 55 or older?
boolean
C0001779 (UMLS CUI [1])
Item
If female, ist the subject pregnant?
text
C0032961 (UMLS CUI [1])
Code List
If female, ist the subject pregnant?
CL Item
Not applicable (X)
Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as a liver ultrasound, computerized tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
Item
Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as a liver ultrasound, computerized tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
boolean
C0011923 (UMLS CUI [1])
C1711359 (UMLS CUI [2])
C0023884 (UMLS CUI [3])
C1456803 (UMLS CUI [4])
C0040405 (UMLS CUI [5])
C0436427 (UMLS CUI [6])
C0024485 (UMLS CUI [7])
C0008310 (UMLS CUI [8])
If diagnostic imaging tests have been performed, were results normal?
Item
If diagnostic imaging tests have been performed, were results normal?
boolean
C1274040 (UMLS CUI [1,1])
C0011923 (UMLS CUI [1,2])
Were any liver biopsies performed?
Item
Were any liver biopsies performed?
boolean
C0193388 (UMLS CUI [1])
Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
Item
Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
boolean
C2240391 (UMLS CUI [1])
C1148474 (UMLS CUI [2])
C0002346 (UMLS CUI [3])
C0242295 (UMLS CUI [4])
C0281875 (UMLS CUI [5])
Did the subject fast or undergo significant dietary change in the past week?
Item
Did the subject fast or undergo significant dietary change in the past week?
boolean
C0015663 (UMLS CUI [1])
C3671772 (UMLS CUI [2])
Was a pharmacokinetic blood sample obtained?
Item
Was a pharmacokinetic blood sample obtained?
boolean
C0005834 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
If Yes, date and time sample taken
Item
If Yes, date and time sample taken
datetime
C0011008 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0040223 (UMLS CUI [2,1])
C0200345 (UMLS CUI [2,2])
If Yes, date and time of last investigational product dose prior to PK sample
Item
If Yes, date and time of last investigational product dose prior to PK sample
datetime
C0304229 (UMLS CUI [2,1])
C1762893 (UMLS CUI [2,2])
C0304229 (UMLS CUI [3,1])
C0946444 (UMLS CUI [3,2])
Sample Identifier Label
Item
Sample Identifier Label
text
C0178913 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Sample Number
Item
Sample Number
text
C1299222 (UMLS CUI [1])
Record the average number of units of alcohol1 consumed per week
Item
Record the average number of units of alcohol1 consumed per week
integer
C0001948 (UMLS CUI [1])
C0560579 (UMLS CUI [2])
Item
Specific Condition
integer
C0012634 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Code List
Specific Condition
CL Item
Acute Viral Hepatitis A (1)
CL Item
Chronic Hepatitis B (2)
CL Item
Chronic Hepatitis C (3)
CL Item
Cytomegalovirus Hepatitis (4)
CL Item
Epstein Barr Virus Infectious Mononucleosis (5)
CL Item
Herpes Simplex Hepatitis (6)
CL Item
Alcoholic Liver Disease (7)
CL Item
Non-alcoholic Steatohepatitis (8)
CL Item
Hepatic Cirrhosis (10)
CL Item
Hemochromatosis (11)
CL Item
Autoimmune Hepatitis (12)
CL Item
Gallbladder disease (13)
Item
Condition Status
integer
C3176928 (UMLS CUI [1])
Code List
Condition Status
CL Item
No Medical Condition (5)
Item
Drug Related Liver Disease Conditions
integer
C0023895 (UMLS CUI [1,1])
C0277579 (UMLS CUI [1,2])
Code List
Drug Related Liver Disease Conditions
CL Item
Drug related liver disease (14)
Item
Condition Status
integer
C3176928 (UMLS CUI [1])
Code List
Condition Status
CL Item
No Medical Condition (5)
Specific Condition
Item
Specific Condition
text
C0012634 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Item
Condition Status
integer
C3176928 (UMLS CUI [1])
Code List
Condition Status
Item
Specific Condition
integer
C0012634 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Code List
Specific Condition
CL Item
Drug Allergies (17)
CL Item
Rheumatoid Arthritis (18)
CL Item
Thyroid Disease (20)
CL Item
Inflammatory Bowel Disease (21)
CL Item
Sjogren’s Syndrome (23)
Item
Condition Status
integer
C3176928 (UMLS CUI [1])
Code List
Condition Status
CL Item
No Medical Condition (5)
Date of hepatic or liver imaging test
Item
Date of hepatic or liver imaging test
date
C2711860 (UMLS CUI [1])
C0011008 (UMLS CUI [2])
Item
What method was used for this imaging test?
integer
C2711860 (UMLS CUI [1])
C1275506 (UMLS CUI [2])
Code List
What method was used for this imaging test?
CL Item
Ultrasound - transabdominal (1)
CL Item
Ultrasound - endoscopic (2)
CL Item
Magnetic Resonance Imaging (MRI) (3)
CL Item
Computerised Tomography (CT) (4)
CL Item
Endoscopic Retrograde Cholangiopancreatography (ERCP) (5)
CL Item
Positron Emission Tomography (PET) (6)
CL Item
Positron Emission Tomography/Computed Tomography (PET/CT) (7)
CL Item
Other, specify (8)
Specify other method for imaging
Item
Specify other method for imaging
text
C2711860 (UMLS CUI [1,1])
C1275506 (UMLS CUI [1,2])
C0205394 (UMLS CUI [2])
C2348235 (UMLS CUI [3])
Item
Are images technically adequate?
text
C0806487 (UMLS CUI [1])
Code List
Are images technically adequate?
CL Item
Readable, but not optimal (2)
CL Item
Other, specify (OT)
Specify other image quality
Item
Specify other image quality
text
C0806487 (UMLS CUI [1])
C0205394 (UMLS CUI [2])
C2348235 (UMLS CUI [3])
Item
A. Indicate the liver size
text
C0426688 (UMLS CUI [1])
Code List
A. Indicate the liver size
CL Item
Hypertrophy (or enlarged) (A2)
CL Item
Atrophy (or smaller than normal) (A3)
CL Item
Segmental hypertrophy (A4)
CL Item
Other, specify (A99)
Specify other liver size
Item
Specify other liver size
text
C0426688 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [2])
Item
B. Indicate the liver texture
text
C0679033 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
Code List
B. Indicate the liver texture
CL Item
Heterogeneous (B2)
CL Item
Sugestive of fibrosis (B3)
CL Item
Nodular or suggestive or cirrhosis (B4)
CL Item
Other, specify (B99)
Specify other liver texture
Item
Specify other liver texture
text
C1285481 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [2])
Item
C. Grade the diffuse and/or geographic fatty infiltrate of the liver
text
C0015695 (UMLS CUI [1])
C0205219 (UMLS CUI [2])
C1517526 (UMLS CUI [3])
C0332448 (UMLS CUI [4])
Code List
C. Grade the diffuse and/or geographic fatty infiltrate of the liver
CL Item
Not applicable - no fatty infiltration (C1)
CL Item
Mild (<= 25%) (C2)
CL Item
Moderate (>25 to <75%) (C3)
CL Item
Severe (>=75%) (C4)
CL Item
Other, specify (C99)
Specify other diffuse and/or geographic fatty infiltrate
Item
Specify other diffuse and/or geographic fatty infiltrate
text
C0015695 (UMLS CUI [1])
C0205219 (UMLS CUI [2])
C1517526 (UMLS CUI [3])
C0205394 (UMLS CUI [4])
C2348235 (UMLS CUI [5])
Item
D. Ascites present
text
C0003962 (UMLS CUI [1])
Code List
D. Ascites present
CL Item
None present (D1)
CL Item
Yes - small amount (D2)
CL Item
Yes - moderate or severe amount (D3)
CL Item
Other, specify (D99)
Specify other ascites
Item
Specify other ascites
text
C0003962 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [2])
Item
E. Are Focal Hepatic Lesions characterisable?
text
C0577053 (UMLS CUI [1,1])
C0205234 (UMLS CUI [1,2])
Code List
E. Are Focal Hepatic Lesions characterisable?
CL Item
Not applicable - no hepatic lesions (E0)
CL Item
Focal Nodular Hyperplasia (E4)
CL Item
Other, specify (E99)
Specify other focal hepatic lesion
Item
Specify other focal hepatic lesion
text
C0577053 (UMLS CUI [1,1])
C0205234 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Item
F. Gallstones or gallbladder lesions?
text
C3842395 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
Code List
F. Gallstones or gallbladder lesions?
CL Item
Gallbladder polyp(s) (F2)
CL Item
Gallbladder wall thickening/oedema (F4)
CL Item
Gallbladder wall gas (F5)
CL Item
Cholecystitis (F6)
CL Item
Gallbladder wall calcification (F7)
CL Item
Gallbladder mass (F8)
CL Item
Other, specify (F99)
Specify other gallstones or gallbladder lesions.
Item
Specify other gallstones or gallbladder lesions.
text
C3842395 (UMLS CUI [1])
C0221198 (UMLS CUI [2])
C0205394 (UMLS CUI [3])
C2348235 (UMLS CUI [4])
Item
G. Biliary ductal lesions?
text
C0005423 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
Code List
G. Biliary ductal lesions?
CL Item
bIntrahepatic ductal dilation (focal involving the right hepatic lobe) (G1)
CL Item
Intrahepatic dutal dilation (focal involving the left hepatic lobe) (G2)
CL Item
Intrahepatic ductal dilation (involving both right and left hepatic lobes) (G3)
CL Item
Extrahepatic ductal dilation (G4)
CL Item
Diffuse ductal dilation (involving both intrahepatic and extrahepatic ducts) (G5)
CL Item
Primary sclerosing cholangitis (G7)
CL Item
Choledocholithiasis (gallstone in duct) (G8)
CL Item
Ductal filling defect(s), other than gallstone (G9)
CL Item
Ductal wall thickening or oedema (G10)
CL Item
Choledochal cyst (G11)
CL Item
Ductal mass (G12)
CL Item
Extrinsic mass compressing bile duct(s) (G13)
CL Item
Other, specify (G99)
Specify other biliary duct lesion
Item
Specify other biliary duct lesion
text
C0005423 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
C0205394 (UMLS CUI [2])
C2348235 (UMLS CUI [3])
Item
H. Portal/Hepatic vein abnormalities?
text
C0032718 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
C0019155 (UMLS CUI [2,1])
C1704258 (UMLS CUI [2,2])
Code List
H. Portal/Hepatic vein abnormalities?
CL Item
Portal vein enlargement (H1)
CL Item
Hepatic vein enlargement (H2)
CL Item
Nonocclusive portal vein thrombus (H3)
CL Item
Occlusive portal vein thrombosis - bland (H4)
CL Item
Hepatic vein thrombosis - bland (H5)
CL Item
Occlusive portal vein thrombosis - malignant (H6)
CL Item
Hepatic vein thrombosis - malignant (H7)
CL Item
Involvement of the main portal vein (H8)
CL Item
Involvement of the right portal vein (H9)
CL Item
Involvement of the left portal vein (H10)
CL Item
Budd-Chiari syndrome (H11)
CL Item
other, specify (H99)
Specify other portal/hepatic vein abnormalities.
Item
Specify other portal/hepatic vein abnormalities.
text
C0019155 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
C0032718 (UMLS CUI [2,1])
C1704258 (UMLS CUI [2,2])
C0205394 (UMLS CUI [3])
C2348235 (UMLS CUI [4])